Based on the multiplex immunoassay profiling, we observed that there were higher expressions of VEGF-A, MCP-1, MMP-1, TNF-α, and CD40L in the CSF samples of CPP patients in comparison to non-tumor patients (Figure 2 and Table 1). The gene discussed is MMP1; the disease is central precocious puberty.